We identified a novel transcription regulation of NRF2 by SOX17, and silencing of SOX17 leads to the activation of NRF2-mediating cytoprotective programs, resulting in CCRT resistance of ESCC cells. Here, SOX17 is linked to esophageal squamous cell carcinoma.